z-logo
open-access-imgOpen Access
Low‐dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson's disease symptoms without side effects
Author(s) -
Wakade Chandramohan,
Chong Raymond,
Bradley Eric,
Morgan John C.
Publication year - 2015
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.232
Subject(s) - niacin , medicine , gastroenterology , pittsburgh sleep quality index , pharmacology , anesthesia , sleep quality , insomnia
Key Clinical Message A 65‐year‐old male, Parkinson's disease patient, was evaluated for GPR 109A expression, niacin index, UPDRS scale, handwriting test, and quality of sleep with and without niacin treatment. The evaluation was repeated 3 months after niacin was stopped. Niacin modulated the abovementioned parameters and showed the overall improvement without side effects.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here